A Foundational Framework

MaRS Innovation’s disclosure pipeline is sourced by one of the world’s leading academic clusters. Our members include four universities, nine teaching and research hospitals and two specialized research institutions, along with MaRS Discovery District.

In five years, we’ve reviewed over 1,000 novel disclosures ranging from drug development projects to medical devices to mobile technology and electronics projects in the physical sciences.

When MaRS Innovation accepts a disclosure of intellectual property from one of our member institutions, we ensure the project receives the early-stage technology development it needs to reach the market, which is often the greatest commercialization obstacle.

Through our embedded management model, MI staff act as project managers for the licensable technologies or spin-off companies, working within deal or founding teams to provide hands-on management and business development while mentoring academic inventors in best entrepreneurial practices.

Our portfolio currently includes 20 licensable technologies and 20 spin-off companies, as well as 30 early-stage opportunities.

Some projects are currently operating in quiet mode and are therefore not listed here. Others are being added to the appropriate section on an ongoing basis.

Contact us for more information about our full portfolio.